On March 6, 2016, Dr. Jorge Castillo spoke to the Philadelphia IWMF Support Group on Genomic-based Advances in WM. To view his presentation, see the link below.
Dr. Castillo, of the Dana-Farber Cancer Institute, is one of the world’s leading clinicians for Waldenstrom’s macroglobulinemia, and provides a valuable perspective, especially since:
- There are approximately 1,500 WM patients diagnosed each year in the United States.
- Dr. Castillo sees approximately 750 WM patients each year!
- Most community oncologists see 0, 1, 2, or 3 WM patients in their career, Dr. Castillo probably sees more WM patients in a morning than most oncologists see in a lifetime.
His trip to Philadelphia and the taping of his presentation were made possible by an unrestricted educational grant from Idera Pharmaceuticals, Inc. We are grateful to Idera for their generous support. And we are grateful to the co-leaders of the Philadelphia Support Group, Lisa Wise and Ross Schmucki, for organizing Dr. Castillo’s trip and the taping of his presentation. Thanks to their efforts, WMers worldwide can view Dr. Castillo’s presentation.
As you schedule time to watch this presentation, be aware it is more informal and longer than what you may be used to from IWMF Educational Forum presentations. It runs for nearly two hours and includes answers to audience questions during and after the presentation.
The video can be found here.
And don’t forget, if you want to see more presentations like this in person, and have an opportunity to ask your own questions of a large number of WM clinicians, researchers and fellow patients and caregivers, consider attending the 2016 Ed Forum in Providence, Rhode Island June 10-12.